Biotech

All Articles

Aligos trumpets stage 2 MASH succeed, reducing liver fat approximately 46%

.Aligos Therapies is declaring a midstage succeed in metabolic-dysfunction affiliated steatohepatiti...

Basilea ratings $268M BARDA financing for antifungals, antibiotics

.Basilea Pharmaceutica's work cultivating brand new antifungals has actually received a substantial ...

Capricor markets Europe civil rights to late-stage DMD treatment for $35M

.Having already scooped up the USA rights to Capricor Therapies' late-stage Duchenne muscular dystro...

FDA scraps adcomm for Applied's unusual health condition medication

.After pushing back the decision meeting for Applied Therapeutics' metabolic condition medication go...

Novo inks $600M NanoVation bargain to study genetic drugs ex-liver

.Novo Nordisk is continuing its push in to genetic medications, accepting pay NanoVation Rehabs up t...

Innovent links cytokine to colon cancer cells responses

.Innovent Biologics has helped make the scenario that its own gate inhibitor-cytokine blend healthy ...

Merck, Daiichi ADC attacks goal in stage 3 lung cancer research study

.A phase 3 trial of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (...

Rakovina grows artificial intelligence focus along with collab to pick cancer cells targets

.Five months after Rakovina Therapeutics pivoted towards artificial intelligence, the cancer-focused...

Ascendis' dwarfism drug favorites in period 3, endangers BioMarin

.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, reporting stage 3...

Despite ph. 3 skip, Alkeus finds course in advance for eye condition possession

.Though Alkeus Pharmaceuticals' dental eye illness asset neglected to dramatically lessen geographic...